VYNE Therapeutics
VYNE
#9565
Rank
A$82.27 M
Marketcap
$5.58
Share price
-12.50%
Change (1 day)
66.92%
Change (1 year)

EPS for VYNE Therapeutics (VYNE)

EPS in 2023 (TTM): -$16.57

According to VYNE Therapeutics's latest financial reports the company's current EPS (TTM) is -$17.95. In 2022 the company made an earnings per share (EPS) of -$11.92 an increase over its 2021 EPS that were of -$42.15.

EPS history for VYNE Therapeutics from 2017 to 2023

20182019202020212022-$300-$200-$100$1000companiesmarketcap.com

Annual EPS

Year EPS Change
2023 (TTM)-$16.5739.06%
2022-$11.92-71.72%
2021-$42.15-84.19%
2020-$266.63-26.29%
2019-$361.7528.75%
2018-$280.9710.79%
2017-$253.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.54-80.25%๐Ÿ‡บ๐Ÿ‡ธ USA